An Introduction to Quantitative Aspects of Quality Improvement Science.

IF 3.2 Q3 CLINICAL NEUROLOGY

Neurology. Clinical practice Pub Date : 2025-10-01 Epub Date: 2025-08-11 DOI:10.1212/CPJ.0000000000200518

Jeffrey Buchhalter, Emily Klatte, Zachary M Grinspan, Justin Martello, Michael S Phipps, Lidia Moura

引用次数: 0

Abstract

The use of quality improvement (QI) has become widespread in medicine to improve patient and process outcomes through the methodology of improvement science. Each project follows a format that includes precisely specifying an aim, drivers/barriers to achieving that aim, and potential change concepts/interventions. It is then necessary to define how the data will be collected and displayed and how the significance of the change due to the interventions will be assessed. In this article, we describe the quantitative methods to provide a framework for the performance and reporting of QI projects.

查看原文本刊更多论文

质量改进科学定量方面导论。

质量改进（QI）的使用已经在医学中广泛使用，通过改进科学的方法来改善患者和过程的结果。每个项目都遵循一种格式，包括精确指定一个目标、实现该目标的驱动因素/障碍，以及潜在的变化概念/干预措施。然后有必要确定如何收集和显示数据，以及如何评估干预措施造成的变化的重要性。在本文中，我们描述了为QI项目的性能和报告提供框架的定量方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurology. Clinical practice CLINICAL NEUROLOGY-

CiteScore

4.00

自引率

0.00%

发文量

期刊介绍： Neurology® Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. The journal publishes original articles in all areas of neurogenetics including rare and common genetic variations, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease genes, and genetic variations with a putative link to diseases. Articles include studies reporting on genetic disease risk, pharmacogenomics, and results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology® Genetics, but studies using model systems for treatment trials, including well-powered studies reporting negative results, are welcome.